Dexcom (DXCM) Return on Equity [ROE] (2009 - 2026)
Dexcom's Return on Equity [ROE] was 38.43% in Q3 2026, up 11.23 percentage points from 27.20% a year earlier and up 2.59 percentage points from the prior quarter.
Powered by 
Analysis
Dexcom (DXCM) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Dexcom came in at 34.50%, up 6.87 percentage points from FY2024.
- Return on Equity [ROE] has now increased for four consecutive years, though with a five-year change of -10.66 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was 27.63% in FY2024 (+1.84 pp), 25.78% in FY2023 (+9.43 pp), 16.35% in FY2022 (+4.28 pp) and 12.07% in FY2021 (-33.09 pp).
- The Q3 2026 figure marks the highest quarterly Return on Equity [ROE] in data going back to Q3 2011.
- Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +2.94 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2024 (a gain of 16.23 percentage points); the worst was Q2 2022 (a drop of 26.02 percentage points).
- Per Business Quant data, DXCM's Return on Equity [ROE] in the three quarters before Q3 2026 was 35.84% (Q2 2026), 32.63% (Q1 2026) and 30.57% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 13.20% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 9.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 8.15% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 17.28% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 17.46% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | -4.01% |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 13.69% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 9.36% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 4.56% |
| 10 | Dexcom | 29.81 Bn | 21.63 Bn | 864.40 Mn | 38.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.43% |
| Jun 30, 2026 | 35.84% |
| Mar 31, 2026 | 32.63% |
| Dec 31, 2025 | 30.57% |
| Sep 30, 2025 | 27.20% |
| Jun 30, 2025 | 23.62% |
| Mar 31, 2025 | 24.50% |
| Dec 31, 2024 | 28.23% |
| Sep 30, 2024 | 30.85% |
| Jun 30, 2024 | 28.49% |
| Mar 31, 2024 | 29.63% |
| Dec 31, 2023 | 24.97% |
| Sep 30, 2023 | 17.26% |
| Jun 30, 2023 | 16.50% |
| Mar 31, 2023 | 13.40% |
| Dec 31, 2022 | 17.25% |
| Sep 30, 2022 | 11.96% |
| Jun 30, 2022 | 10.36% |
| Mar 31, 2022 | 12.18% |
| Dec 31, 2021 | 10.97% |
API Access
Dexcom Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DXCM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DXCM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DXCM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();